Terms: = Pancreatic cancer AND FANCD2, FANCD, 2177, ENSG00000144554, FLJ23826, FAD, FACD, FA4, FA-D2, FAD2, DKFZp762A223 AND Prognosis
4 results:
1. Multiomics identifies metabolic subtypes based on fatty acid degradation allocating personalized treatment in hepatocellular carcinoma.
Li B; Li Y; Zhou H; Xu Y; Cao Y; Cheng C; Peng J; Li H; Zhang L; Su K; Xu Z; Hu Y; Lu J; Lu Y; Qian L; Wang Y; Zhang Y; Liu Q; Xie Y; Guo S; Mehal WZ; Yu D
Hepatology; 2024 Feb; 79(2):289-306. PubMed ID: 37540187
[TBL] [Abstract] [Full Text] [Related]
2. Crosstalk of ferroptosis regulators and tumor immunity in pancreatic adenocarcinoma: novel perspective to mRNA vaccines and personalized immunotherapy.
Shi Y; Wang Y; Dong H; Niu K; Zhang W; Feng K; Yang R; Zhang Y
Apoptosis; 2023 Oct; 28(9-10):1423-1435. PubMed ID: 37369808
[TBL] [Abstract] [Full Text] [Related]
3. Identification and Validation of Hub Genes Predicting prognosis of Hepatocellular Carcinoma.
Chen Z; Yu H; Wu L; Zhang S; Lin Z; Deng T; He B; Yu Z; Chen G; Wu F
Dig Surg; 2022; 39(1):24-31. PubMed ID: 34788753
[TBL] [Abstract] [Full Text] [Related]
4. Enzymes involved in l-lactate metabolism in humans.
Adeva M; González-Lucán M; Seco M; Donapetry C
Mitochondrion; 2013 Nov; 13(6):615-29. PubMed ID: 24029012
[TBL] [Abstract] [Full Text] [Related]
